Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2
RESEARCH TOOLSreports
Supernus Pharmaceuticals (0LB2) Ownership - Who Owns Supernus Pharmaceuticals?
0 Followers
Supernus Pharmaceuticals (0LB2) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.94% Other Institutional Investors
95.06% Public Companies and
Individual Investors
The ownership structure of Supernus Pharmaceuticals (GB:0LB2) stock is a mix of institutional, retail and individual investors. Approximately 4.94% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 95.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 17, 2023 | Frederick Hudson Director | Sold | $259151 |
| Nov 16, 2023 | Frank Mottola Svp, Quality, Gmp, Ops, It | Sold | $31224 |
| Sep 01, 2023 | Tami Tillotson Martin Sr. V.p., Regulatory Affairs | Sold | $259200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $347453 | |
| Dec 31, 2023 | Sold | $2187864 | |
| Dec 31, 2023 | Bought | $4622209 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 230,710 | Insider | ― | 6,796,717 | |
| 2,772 | Insider | ― | 81,663 | |
| 47,500 | Insider | ― | 1,399,350 | |
| 212,650 | Insider | ― | 6,264,669 | |
| 44,463 | Insider | ― | 1,309,880 | |
| 20,547 | Insider | ― | 605,315 | |
| 1,937,667 | Insider | ― | 57,083,670 | |
| 120,975 | Insider | ― | 3,563,924 | |
| 67,980 | Insider | ― | 2,002,691 | |
| 9,344 | Insider | ― | 275,274 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 55,347 | Institution | ― | 1,630,523 | |
| 68,898 | Institution | ― | 2,029,735 | |
| 21,366 | Institution | ― | 629,442 | |
| 41,033 | Institution | ― | 1,208,832 | |
| 7,162 | Institution | ― | 210,993 | |
| 13,715 | Institution | ― | 404,044 | |
| 39,646 | Institution | ― | 1,167,971 | |
| 62,335 | Institution | ― | 1,836,389 | |
| 279,636 | Institution | ― | 8,238,077 | |
| 81,126 | Institution | ― | 2,389,972 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Supernus Pharmaceuticals (GB:0LB2)?
According to the latest TipRanks data, approximately 4.94% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 95.06% is held by retail investors.
What percentage of Supernus Pharmaceuticals (GB:0LB2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.94% of Supernus Pharmaceuticals (GB:0LB2) stock is held by institutional investors.
What percentage of Supernus Pharmaceuticals (GB:0LB2) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.06% of Supernus Pharmaceuticals (GB:0LB2) stock is held by retail investors.
Who owns the most shares of Supernus Pharmaceuticals (GB:0LB2)?
James Barrett owns the most shares of Supernus Pharmaceuticals (GB:0LB2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.